Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Varonis Systems Q2 2025 Earnings Call - SaaS ARR hits 69%, powering 19% ARR growth and strong cash generation
Varonis reported solid Q2 execution as its SaaS transition accelerates: ARR reached $693.2M, up 19% year over year, with SaaS now about 69% of ARR. Revenue was $152.2M (up 17%), gross margin held at 8...
- ARR reached $693.2 million in Q2 2025, up 19% year over year.
- SaaS ARR now represents roughly 69% of total ARR (about $475 million), an ~8 percentage point increase from Q1.
- Quarterly revenue was $152.2 million, up 17% year over year; SaaS revenue was $105.9 million.
- +15 more takeaways
Newell Brands Q2 2025 Earnings Call - Pricing and productivity to absorb permanent tariffs, holding margin momentum amid weak sales
Newell posted a quarter of margin momentum and tariff triage, even as core sales remain soft. Q2 normalized operating margin rose to 10.7% and normalized gross margin hit 35.6%, the eighth straight qu...
- Q2 normalized operating margin was 10.7%, up 10 basis points year over year, and normalized gross margin rose 80 basis points to 35.6%, the highest in four years and eighth consecutive quarter of gross-margin improvement.
- Normalized EPS was $0.24, at the top of guidance, despite a higher-than-expected effective tax rate of 19.2% which reduced EPS by about $0.02.
- Core sales fell 4.4% in Q2; first-half 2025 core sales were down 3.4%, a deterioration versus the steady sequential improvement delivered since the 2023 strategy rollout.
- +15 more takeaways
Avient Corporation Q2 2025 Earnings Call - Modest organic growth, margin expansion and a ramp to $40M of productivity savings
Avient posted a cautious but constructive quarter: Q2 organic sales edged up 0.6%, adjusted EPS came in at $0.80 (ahead of guidance), and adjusted EBITDA margin widened to 17.2% as the company pushed ...
- Q2 organic sales grew 0.6%, marking the fifth consecutive quarter of organic growth for Avient.
- Adjusted EPS was $0.80, up 5% and slightly ahead of guidance of $0.79.
- Adjusted EBITDA margin expanded to 17.2%, a 30 basis point improvement driven by favorable mix, productivity and disciplined discretionary spend.
- +12 more takeaways
VF Corporation Q1 FY26 Earnings Call - Transformation shows progress but tariffs and Vans drag near-term growth
VF posted a mixed Q1: revenue of $1.8 billion was flat on a reported basis and down 2% in constant dollars, but the company beat guidance on profitability with an adjusted Q1 loss of $56 million, roug...
- Q1 revenue $1.8 billion, flat reported, down 2% in constant dollars; results came in above guidance.
- Adjusted Q1 loss approximately $56 million, about $50 million better than the high end of guidance; adjusted EPS loss $0.24 vs $0.35 prior year.
- Adjusted gross margin improved ~200 basis points to 54.1%, driven by higher quality inventory, fewer discounts, and FX tailwinds. SG&A dollars were flat year over year. Adjusted operating margin was negative 3.2%, a 270 basis point improvement.
- +11 more takeaways
Huron Consulting Group Q2 2025 Earnings Call - Record RBR and raised guidance as healthcare pressure fuels consulting demand, digital sales slow
Huron reported a milestone quarter, hitting record RBR of $402.5 million, driving management to raise full year RBR and EPS guidance while holding margin targets steady. Growth was broad based, led by...
- Record RBR of $402.5 million in Q2 2025, up 8.3% year over year; organic RBR growth was 4.2%.
- Management raised full year RBR guidance to $1.64 billion to $1.68 billion, and increased adjusted non-GAAP EPS guidance to $7.30 to $7.70, while keeping adjusted EBITDA margin guidance at 14.0% to 14.5% of RBR.
- Healthcare segment RBR was $197.8 million, ~49% of company RBR, with consulting/performance improvement strength offsetting softer digital sales conversions in some large transformation deals.
- +13 more takeaways
Axalta Q2 2025 Earnings Call - Record EBITDA and EPS Despite Persistent Refinish Weakness; Stabilization Eyed in 2026
Axalta delivered a counterintuitive quarter, posting record adjusted EBITDA of $292 million and record adjusted diluted EPS of $0.64, even as consolidated net sales fell roughly 3% to about $1.3 billi...
- Record adjusted EBITDA of $292 million and record adjusted diluted EPS of $0.64 in Q2, despite a tougher top line environment.
- Consolidated net sales were about $1.3 billion, down approximately 3% year over year, driven by volume weakness in Performance Coatings.
- Adjusted EBITDA margin expanded 90 basis points year over year to 22.4%, marking the fifth straight quarter at or above the A Plan 21% margin target.
- +12 more takeaways
Axalta Q2 2025 Earnings Call - Record EBITDA and EPS, Refinish Headwinds Likely to Persist Into 2026
Axalta delivered a big quarter on profitability while the top line creaked. Q2 produced record adjusted EBITDA and adjusted diluted EPS on disciplined cost control and pricing, but consolidated net sa...
- Q2 net sales approximately $1.3 billion, down about 3% year over year, in line with guidance.
- Record adjusted EBITDA of $292 million, adjusted EBITDA margin expanded to ~22.4%, fifth consecutive quarter at or above the A Plan 21% target.
- Adjusted diluted EPS was $0.64 in Q2, up about 5% year over year, marking a quarterly earnings record.
- +12 more takeaways
Credit Acceptance Corporation Q2 2025 Earnings Call - Loan underperformance trims forecasted cash flows despite record $9.1B portfolio
Credit Acceptance reported a record adjusted loan portfolio of $9.1 billion, yet saw forecasted net cash flows fall by $56 million, a 0.5% decline, as 2022 through 2024 vintages underperformed expecta...
- Adjusted loan portfolio reached a record $9.1 billion, up 6% year over year on an adjusted basis.
- Forecasted net cash flows declined 0.5%, a $56 million reduction during the quarter.
- Loan performance: 2022, 2023 and 2024 vintages underperformed expectations; 2025 vintage is outperforming.
- +12 more takeaways
Bausch + Lomb Q2 2025 Earnings Call - Dry-eye and contact-lens momentum offsets Invista recall; guidance raised
Bausch + Lomb reported a resilient Q2 2025, with revenue of $1.278 billion, 3% constant-currency growth, and an upbeat raise to full-year guidance despite the lingering drag from the Invista IOL recal...
- Q2 revenue $1.278 billion, 3% year-over-year constant-currency growth; excluding Invista recall the company says revenue growth would have been 6%.
- Company raised 2025 revenue guidance from $5.00-5.10 billion to $5.05-5.15 billion, and adjusted EBITDA guidance from $850-900 million to $860-910 million.
- Invista IOL recall cost roughly $29 million of revenue in Q2, and a one-time $19 million hit to adjusted EBITDA; management expects full momentum to be recaptured by Q1 2026.
- +14 more takeaways
Piper Sandler Companies Q2 2025 Earnings Call - Advisory-Led Rebound Lifts Revenues and Margins, Corporate Financing Lags
Piper Sandler rode a clear advisory-led recovery in Q2, delivering $405 million of adjusted net revenues, an 18.1% operating margin, and $2.95 of adjusted EPS. Advisory strength, led by Services & Ind...
- Adjusted net revenues were $405 million in Q2 2025, with an 18.1% adjusted operating margin and $2.95 adjusted diluted EPS.
- Advisory revenues totaled $206 million in Q2, up 12% year over year, with 71 completed transactions during the quarter.
- Advisory momentum is broad based, Services and Industrials delivered one of its best quarters since 2021, and overall advisory for H1 was $423 million, up 24% year over year.
- +14 more takeaways